AbCellera Biologics Inc. (ABCL) scores 39 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $3.25, representing a 4% premium to fair value. Quantitative score: 54/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.